Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer
PRIORITY
1 other identifier
observational
346
1 country
1
Brief Summary
The main objective of study is to describe the priorities of elderly patients (70 years and over) undergoing a first medical treatment for cancer, at initiation of treatment and after 3 months of treatment. The main criterion is a prioritization of 4 items per patient from a list of 8 expectations regarding the objectives of their treatment: treatment efficacy, life expectancy, autonomy, daily activities, social activities, heaviness of treatment, toxicity, economics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 14, 2016
CompletedFirst Posted
Study publicly available on registry
July 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedResults Posted
Study results publicly available
July 1, 2025
CompletedJuly 1, 2025
November 1, 2024
6.5 years
June 14, 2016
June 10, 2025
June 10, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation
Prioritization among of the 4 items selected from a list of 8 expectations regarding the objectives of their treatment : treatment efficacy, life expectancy, autonomy, daily tasks, social activities, burden of treatment, toxicity and economic burden. For each expectation, the number and rate of priorization are reported.
Day 0 initiation of treatment
Priorities of Patients Receiving First Medical Treatment for Cancer 3 Months After Initiation of Treatment
Prioritization among of the 4 items selected from a list of 8 expectations regarding the objectives of their treatment : treatment efficacy, life expectancy, autonomy, daily tasks, social activities, burden of treatment, toxicity and economic burden. For each expectation, the number and rate of priorization are reported.
3 months after initiation of treatment
Secondary Outcomes (5)
Expectations of Patients at Initiation of Treatment
Day 0 initiation of treatment
Expectations of Patients 3 Months After Initiation of Treatment
3 months after initiation of treatment
Stability of Patients in Their Priorities at 3 Months
3 months after initiation of treatment
1-year Overall Survival
From inclusion to the end of study
Agreement Rate for Prioritization of Expectations Between Patients and Physicians
Day 0 initiation of treatment
Study Arms (2)
Elderly patient (70 years and older)
Young patient (18 years - 69 years)
Interventions
Consultation, evaluation questionnaire
Geriatric consultation, evaluation questionnaire
Eligibility Criteria
400 patients aged 70 years old or more and 100 patient between 18 and 69 years old.
You may qualify if:
- Male or female:
- Age ≥ 70 years
- Aged 18-69 years (case population)
- ECOG / performance status 0-3 (WHO).
- First line of medical oncology treatment (chemotherapy, targeted therapy, hormone therapy, combination):
- Neo-adjuvant setting,
- Adjuvant setting: previous neo-adjuvant treatment is allowed,
- Metastatic setting: previous neo-adjuvant and/or adjuvant treatment are allowed,
- Solid tumors (breast, colorectal, kidney, lung, prostate, sarcoma, and ovarian) and lymphoma (indolent and aggressive).
- Life expectancy of more than 3 months.
- Patients potentially compliant with the rules of the follow-up study.
- Patients affiliated to a social security scheme.
- Patients who received clear information from the investigator on the study and had not refused to participate.
You may not qualify if:
- Exclusive surgery treatment.
- Exclusive radiotherapy treatment or in combination with oncological medical treatment (concomitant radio-chemotherapy or radio-hormonotherapy).
- Neo-adjuvant setting: previous line(s) of neo-adjuvant medical treatment,
- Adjuvant setting: previous line(s) of adjuvant medical treatment,
- Metastatic setting: previous line(s) of metastatic medical treatment,
- Supportive care without specific medical treatment
- Patient already included in this study
- Patient who for psychological, psychiatric, social, family or geographical reasons could not be regularly monitored according to the criteria of the study; patient private of liberty or under guardianship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Bergoniélead
- Fondation Université de Bordeauxcollaborator
- AG2R La Mondialecollaborator
Study Sites (1)
Institut Bergonié
Bordeaux, 33076, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Pr Simone Mathoulin-Pelissier
- Organization
- Institut Bergonié
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2016
First Posted
July 4, 2016
Study Start
January 1, 2016
Primary Completion
June 30, 2022
Study Completion
December 31, 2023
Last Updated
July 1, 2025
Results First Posted
July 1, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share